Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater

/in , , /by

Loveland, Colo. – Hach® (www.hach.com), a global leader in water analysis and LuminUltra (luminultra.com), a global leader in biological diagnostic testing, have partnered to offer the world’s first rapid, on-site testing solution for the detection of SARS-CoV-2 in wastewater. SARS-CoV-2 is the virus that causes COVID-19. The partnership is a direct response to consumer and […]

Read more →

Miroculus Closes Extension to $45M Series B Financing

/in , , , /by

Cota Capital and Section 32 join as investors to support the launch of the Miro Canvas, Miroculus’ first commercial platform. Miroculus, Inc., a developer of revolutionary tools for personal lab automation, today announced the completion of a Series B extension, bringing the total capital raised in the series to $45M. “This round of financing will […]

Read more →

Porvair Sciences new Krystal™ Glass Bottom microplate with Schott D 263® M technology provides unmatched performance for whole-plate CCD imaging and laser detection applications. Krystal™ Glass Bottom plates combine the advantageous optical properties of glass, low background and low birefringence, with the versatility of a microplate. Constructed in ultra-pure grade borosilicate glass – the new D 263® M, Krystal™ Glass Bottom microplate is precision manufactured for high optical performance in high resolution microscopy applications. These glass bottom plates offer high optical quality, thermal stability, chemical resistance, and low autofluorescence to suit a wide range of samples for accurate and reliable light and fluorescence readings. Due to the high clarity bottom of Schott D 263® M glass, exact positioning of the microplate on microscopes and imaging apparatus can be made with ease. The latest Krystal™ microplate is available in different thicknesses: 50 µm, 175 µm and in addition, a high-performance version D 263® M / 1.5H plate with a thickness tolerance of +/- 5 µm is also available for high sensitivity applications. Precisely manufactured to SBS / ANSI microplate dimensions the affordable Krystal™ Glass Bottom design is fully compatible with all commercially available plate readers, robotic sample processors and automated liquid handling systems. The complete Krystal™ range of glass bottom microplates is available tissue culture treated to optimise cell growth or without surface modification. The Porvair Sciences Krystal™ glass bottom plate range demonstrate higher performance than standard polystyrene plates for fluorescence assays, luminescence detection, scintillation counting and high-resolution microscopy using confocal imaging. For further information on Krystal™ Glass Bottom microplates please visit https://www.microplates.com/krystal-clear-bottom-opaque-sides/ or contact Porvair Sciences Ltd on +44 1978 666222 / +1 800 552 3696 / int.sales@porvairsciences.com Established in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates, top quality microplate equipment, and sample preparation technologies for analytical sciences. Throughout North America, Porvair Sciences products are available and locally supported from sister company, JG Finneran Associates Inc., which also designs, manufactures, and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates, and closures. Porvair Sciences and JG Finneran is a wholly owned subsidiary of Porvair plc. * D 263® M is a registered trademark of SCHOTT Technical Glass Solutions GmbH

/in , , , , , /by

New kits improve upon well-established ARTIC protocols for SARS-CoV-2 genome sequencing with optimized reagents and improved uniformity of coverage depth for Illumina® and Oxford Nanopore Technologies® next generation sequencing (NGS) platforms IPSWICH, Mass — New England Biolabs (NEB®) today released three kits based on the ARTIC Network protocols for multiplexed amplicon-based sequencing of viral RNA: NEBNext® ARTIC SARS-CoV-2 […]

Read more →

Children’s Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis

/in , /by

KANSAS CITY, Mo. and MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Children’s Mercy Kansas City, one of the nation’s top pediatric medical centers, has increased its investment in highly accurate HiFi sequencing with four new Sequel IIe Systems to add […]

Read more →

Twist Bioscience Launches Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studies

/in , , , , , /by

— Studying Methylation Patterns Provides Unique Insight into Disease Pathology — — System Improves Accuracy of Results, Allows Capture of Customized Genes of Interest, Operational Efficiency — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today […]

Read more →

QIAGEN and INOVIO expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia

/in , /by

Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions First-in-class next generation sequencing (NGS) assay designed for use on Illumina NextSeq™ 550Dx PLYMOUTH MEETING, PA., USA, and GERMANTOWN, MD., USA, and HILDEN, Germany – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an […]

Read more →

Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data

/in , , , /by

Project Underscores Growing Importance of Efficient Genomic Data Management, Visibility and Retrieval BOSTON –  Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. (NYSE: PFE) in the development of a data management and collaboration solution for the biopharmaceutical company’s single-cell ribonucleic acid (RNA) sequencing (scRNASeq) data. The Seven Bridges Platform is a cloud-based […]

Read more →

10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event

/in , , , , , , /by

Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms:  Chromium Single Cell, Visium Spatial, and In […]

Read more →

CVC Credit supports further growth at Calibre Scientific with an incremental $57 million multicurrency credit facility

/in , , , , /by

Funding by CVC Credit has supported five acquisitions since June 2020 CVC Credit is pleased to announce that it has further supported life sciences and diagnostics business, Calibre Scientific, by leading an incremental $57 million multicurrency first lien credit facility to help fuel its ongoing global acquisition strategy. Calibre Scientific is owned by investment firm […]

Read more →

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

/in , , , /by

G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents Dublin, Ireland and Seoul, Korea: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and G+FLAS Life Sciences, Inc. (G+FLAS), a biotechnology company developing research tools and reagents associated with CRISPR […]

Read more →